Literature DB >> 2129174

Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.

G Hall1, M J Lind, M Huang, A Moore, A Gane, J T Roberts, B M Cantwell.   

Abstract

We report three patients who had serious disturbance of anticoagulant control while receiving ifosfamide/mesna-containing cytotoxic chemotherapy in association with warfarin. In view of the likely biological potentiation of warfarin by ifosfamide/mesna, close monitoring of anticoagulant control should be performed during the co-administration of these drugs.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2129174      PMCID： PMC2429713          DOI： 10.1136/pgmj.66.780.860

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

1.  Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.

Authors:  B M Cantwell; J Carmichael; S E Ghani; A L Harris
Journal:  BMJ       Date:  1988-07-16

2.  The effect of cytotoxic agents on drug metabolism.

Authors:  M G Donelli; G Franchi; R Rosso
Journal:  Eur J Cancer       Date:  1970-04       Impact factor: 9.162

3.  Thromboembolic events during combination chemotherapy for germ cell-malignancy.

Authors:  B M Cantwell; K A Mannix; J T Roberts; S E Ghani; A L Harris
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

4.  Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma.

Authors:  M J Lind; J M Margison; T Cerny; N Thatcher; P M Wilkinson
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

5.  Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.

Authors:  I Jardine; C Fenselau; M Appler; M N Kan; R B Brundrett; M Colvin
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

Review 6.  Ifosfamide.

Authors:  M Zalupski; L H Baker
Journal:  J Natl Cancer Inst       Date:  1988-06-15       Impact factor: 13.506
  6 in total
  4 in total

1.  Effect of gefitinib on warfarin antithrombotic activity.

Authors:  Susumu Arai; Hisashi Mitsufuji; Yasuto Nishii; Sayaka Onoda; Shinichiro Ryuge; Mayuko Wada; Ken Katono; Maiko Iwasaki; Akira Takakura; Sakiko Otani; Michiko Yamamoto; Tomoko Yanaihara; Masanori Yokoba; Masaru Kubota; Masato Katagiri; Tomoya Fukui; Hirosuke Kobayashi; Nobuo Yanase; Ryuji Hataishi; Noriyuki Masuda
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

Review 2.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 3.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 4.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.